Companies: 10,795·Total market cap: $144.5T
Laboratorios Farmaceuticos Rovi, S.A.

Laboratorios Farmaceuticos Rovi, S.A.

LABFFOTCHealthcare● Active
$90.61
+$0.00(+0.00%)
Market Cap$4.6B
P/E Ratio
52W High$90.61
52W Low$90.61
Overview

Laboratorios Farmaceuticos Rovi, S.A.(LABFF)· 现金流量表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · LABFF · 截至 2026-06-10

财务报表

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-122021-12
Operating Activities
Net Income$0.14B$0.18B$0.22B$0.26B$0.18B
Depreciation & Amort.$0.03B$0.03B$0.02B$0.02B$0.02B
Stock-Based Comp.$0.00B$0.00B$0.00B$0.00B$0.00B
Change in Working Capital($0.01B)$0.01B($0.03B)($0.06B)($0.06B)
Net Cash from Operations$0.19B$0.14B$0.11B$0.24B$0.15B
Investing Activities
Capital Expenditure($0.07B)($0.06B)($0.06B)($0.05B)($0.04B)
Purchases of Investments($0.00B)$0.00B$0.00B($0.01B)$0.00B
Sales of Investments$0.00B$0.00B$0.00B$0.00B$0.00B
Net Cash from Investing($0.07B)($0.08B)($0.05B)($0.06B)($0.04B)
Financing Activities
Common Stock Repurchased($0.05B)($0.09B)($0.13B)($0.18B)($0.08B)
Dividends Paid($0.05B)($0.06B)($0.07B)($0.05B)($0.02B)
Debt Issued / Repaid$0.00B$0.05B($0.01B)($0.01B)($0.00B)
Net Cash from Financing($0.05B)($0.06B)($0.16B)($0.15B)($0.06B)
Free Cash Flow
Free Cash Flow$0.12B$0.08B$0.06B$0.19B$0.11B
FCF Margin %(computed)16.16%9.96%7.00%22.77%16.73%

数据来源:Financial Modeling Prep · 最后更新:2026-06-10 · EUR · B

深入了解Laboratorios Farmaceuticos Rovi, S.A.

关于Laboratorios Farmaceuticos Rovi, S.A.(LABFF)现金流量表

Laboratorios Farmaceuticos Rovi, S.A. 2025财年经营活动现金流$0.19B,自由现金流$0.12B(FCF利润率16.16%),资本支出($0.07B)。

常见问题

LABFF · 4 问

Laboratorios Farmaceuticos Rovi, S.A. 2025财年自由现金流$0.12B,同比up57.9%。

LABFF free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10